Table 2 Sensitivity analysis of meta-analysis between NLR and mortality.
HR | 95% CI | I2 (%) | |
|---|---|---|---|
Using a fixed-effect model | 1.67 | [1.52, 1.84] | 22 |
All trials | 1.82 | [1.57, 2.11] | 22 |
Excluding trials with Huanhuan Cui 2022 | 1.8 | [1.54, 2.10] | 23 |
Excluding trials with Mudit Chowdhary 2018 | 1.9 | [1.60, 2.26] | 28 |
Excluding trials with Gundu Naresh 2021 | 1.72 | [1.52, 1.94] | 8 |
Excluding trials with Hongwei Li 2020 | 1.81 | [1.54, 2.12] | 24 |
Excluding trials with HIROSHI DOI 2019 | 1.75 | [1.52, 2.01] | 15 |
Excluding trials with Ye Hong 2022 | 1.83 | [1.55, 2.16] | 27 |
Excluding trials with Lukas Käsmann 2017 | 1.83 | [1.56, 2.15] | 27 |
Excluding trials with HelderPicarelli 2022 | 1.79 | [1.54, 2.08] | 22 |
Excluding trials with Lifeng Zhang 2020 | 1.91 | [1.60, 2.27] | 27 |
Excluding trials with Angelika M 2021 | 1.95 | [1.65, 2.31] | 0 |
Excluding trials with Ren BX 2020 | 1.76 | [1.52, 2.05] | 18 |
